---
title: "Maravai LifeSciences (MRVI.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MRVI.US/norm.md"
symbol: "MRVI.US"
name: "Maravai LifeSciences"
parent: "https://longbridge.com/en/quote/MRVI.US.md"
datetime: "2026-05-19T22:39:56.384Z"
locales:
  - [en](https://longbridge.com/en/quote/MRVI.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MRVI.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MRVI.US/norm.md)
---

# Maravai LifeSciences (MRVI.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0255 | -0.2460 | -0.1766 | -0.2745 | -0.2088 |
| ROE | -7.04% | -62.35% | -39.99% | -55.91% | -38.27% |
| Revenue | 65.84M | 49.87M | 41.63M | 47.40M | 46.85M |
| Net income | -3.73M | -35.68M | -25.56M | -39.59M | -29.95M |
| Operating income | 720000.00 | -19.63M | -33.59M | -35.69M | -36.73M |
| Gross margin | 51.19% | 29.16% | 13.58% | 16.39% | 16.49% |
| Net margin | -5.67% | -71.55% | -61.39% | -83.53% | -63.92% |
| Profit quality | 8.31% | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 713.22M | 770.58M | 849.19M | 896.97M | 959.75M |
| Leverage | 1.93 | 2.07 | 1.97 | 1.92 | 1.81 |
| BVPS | 1.43 | 1.46 | 1.70 | 1.84 | 2.09 |
| Turnover | 0.2448 | 0.2088 | 0.1809 | 0.1875 | 0.2012 |
| Cash & STI | 165.92M | 216.89M | 243.57M | 269.91M | 285.05M |
| Inv & Rec | 40.46M | 40.49M | 45.33M | 46.67M | 49.77M |
| LT assets | 146.93M | 190.74M | 158.62M | 162.73M | 166.43M |
| Net debt | 149.11M | 147.82M | 124.37M | 101.17M | 95.94M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 8.66M | -22.77M | -15.15M | -10.27M | -9.39M |
| Investing CF | -4.44M | -2.11M | -2.93M | -3.24M | -23.13M |
| Financing CF | -55.23M | -1.82M | -8.25M | -1.53M | -4.90M |
| Free CF | 5.74M | -9.15M | -223625.00 | 7.60M | 14.95M |
| OCF coverage | 15.53% | -784.02% | -337.72% | -232.19% | -160.21% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -4.44M | -2.11M | -2.93M | -2.87M | -4.50M |